Ironwood Pharmaceuticals Inc (IRWD) income statement
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3063% below fair value
$4.71−0.07 (-1.46%)
Close on Nov 19, 2026Market cap $778.28MP/E 6.1Yield –
Ironwood Pharmaceuticals Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- 60.1%
- Net margin
- 33.4%
- Return on equity, FY2025
- -8.5%
Financial strength
- Current ratio
- 6.06
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 240.8%
Valuation
- P/E ratio
- 6.1
- Price to sales
- 2.00
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?